Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3859 ARTÍCULOS , VIENDO DEL 826 AL 840

Atypical Presentation of Enterovirus D68 Infection as Opsoclonus-Myoclonus Syndrome

Martin MJ, Rose SC.

Pediatr Neurol. 2021 Nov;124:24-25. doi: 10.1016/j.pediatrneurol.2021.07.005. Epub 2021 Aug 4.

Gastrointestinal disorders in hyperkinetic movement disorders and ataxia

Pradeep S, Mehanna R.

Parkinsonism Relat Disord. 2021 Sep;90:125-133. doi: 10.1016/j.parkreldis.2021.09.005. Epub 2021 Sep 14.

Adrenal ganglioneuroma: Prognostic factors (Review)

Sandru F, Dumitrascu MC, Petca A, Carsote M, Petca RC, Oproiu AM, Ghemigian A.

Exp Ther Med. 2021 Nov;22(5):1338. doi: 10.3892/etm.2021.10773. Epub 2021 Sep 22.

Autoimmune mediated hyperkinetic movement disorders in SARS-CoV-2 infection - a systematic review

Hirschfeld AS.

Neurol Neurochir Pol. 2021;55(6):549-558. doi: 10.5603/PJNNS.a2021.0069. Epub 2021 Oct 12.

Opsoclonus-Myoclonus-Associated Neuroblastoma With Bone Marrow Metastases: What Would Be the Best Treatment Option?

Gizhlaryan M, Aghabekyan T, Arakelyan T, Petrosyan M, Iskanyan S, Tamamyan G, Sargsyan L, Papyan R.

Oncology (Williston Park). 2021 Oct 22;35(10):665-667. doi: 10.46883/ONC.2021.3510.0665.

DRPLA: An unusual disease or an underestimated cause of ataxia in Brazil?

Pinto WBVR, Salomão RPA, Bergamasco NC, da Cunha Ribas G, da Graça FF, Lopes-Cendes I, Bonadia L, de Souza PVS, Bulle Oliveira AS, Saraiva-Pereira ML, Jardim LB, Tumas V, Junior WM, França MC Jr, Pedroso JL, Barsottini OGP, Teive HAG.

Parkinsonism Relat Disord. 2021 Nov;92:67-71. doi: 10.1016/j.parkreldis.2021.10.004. Epub 2021 Oct 11.

[Neuronal ceroid lipofuscinosis. Type 6 late infantile variant in two compound heterozygous siblings with novel mutations]

Bravo-Oro A, Saavedra-Alanís VM, Reyes-Vaca JG, Espinosa-Tanguma R, Shiguetomi-Medina JM, Esmer C.

Rev Neurol. 2021 Nov 16;73(10):368-371. doi: 10.33588/rn.7310.2021174.

Creutzfeldt-Jakob disease: A case report

Salehian R, Sina F, Moudi S.

Caspian J Intern Med. 2021;12(Suppl 2):S359-S362. doi: 10.22088/cjim.12.0.359.

Breast cancer-associated opsoclonus-myoclonus syndrome: a case report

Kostoglou A, Vlastos D, Bakalis A, Ghosh D.

World J Surg Oncol. 2021 Nov 16;19(1):328. doi: 10.1186/s12957-021-02436-7.

Movement Disorders Associated with COVID-19

Salari M, Zaker Harofteh B, Etemadifar M, Sedaghat N, Nouri H.

Parkinsons Dis. 2021 Nov 8;2021:3227753. doi: 10.1155/2021/3227753. eCollection 2021.

Adult-onset rapidly worsening progressive myoclonic epilepsy caused by a novel variant in DHDDS

Kim S, Kim MJ, Son H, Hwang S, Kang MK, Chu K, Lee SK, Moon J.

Ann Clin Transl Neurol. 2021 Dec;8(12):2319-2326. doi: 10.1002/acn3.51483. Epub 2021 Nov 27.

A diagnosis of progressive myoclonic ataxia guided by blood biomarkers: Expert commentary

Pollini L, Tijssen MAJ.

Parkinsonism Relat Disord. 2022 Jan;94:127-128. doi: 10.1016/j.parkreldis.2021.12.001. Epub 2021 Dec 7.

Relationship between COVID-19 and movement disorders: A narrative review

Schneider SA, Hennig A, Martino D.

Eur J Neurol. 2022 Apr;29(4):1243-1253. doi: 10.1111/ene.15217. Epub 2021 Dec 31.

[Primary central nervous system post-transplant lymphoproliferative disorder with few specific abnormal findings observed on MRI and in the cerebrospinal fluid]

Takeuchi Y, Ochiai J, Onoda O, Nishihira M, Uchida K, Yoshida M.

Rinsho Shinkeigaku. 2022 Jan 28;62(1):44-48. doi: 10.5692/clinicalneurol.cn-001677. Epub 2021 Dec 18.

Case Report: Opsoclonus-Myoclonus Syndrome Associated With Contactin-Associated Protein-Like 2 and Acetylcholine Receptor Autoantibodies in the Setting of Non-Small Cell Lung Carcinoma

Rosenow CS, Dawit S, Farrugia LP, Henry Ma KA, Sharma A, McKeon A, Porter AB, Grill MF.

Neurohospitalist. 2022 Jan;12(1):100-104. doi: 10.1177/19418744211012899. Epub 2021 May 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias